KLRS FY 2021 Earnings — Kalaris Therapeutics Inc Revenue & Financial Results | Market Cap Arena

KLRSKalaris Therapeutics Inc

$180M

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$1M

Operating Income

-$170M

Net Income

-$172M

EPS (Diluted)

$-63.00

Cash Flow

Operating Cash Flow

-$106M

Free Cash Flow

-$106M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$287M

Total Liabilities

$61M

Stockholders' Equity

$225M

Cash & Equivalents

$202M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$1M	-$73,000	-1430.1%
Operating Income	-$170M	-$71M	-138.1%
Net Income	-$172M	-$70M	-146.4%